- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00222911
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
May 19, 2008 updated by: University of Pittsburgh
Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study
The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Plantar fasciitis is an overuse injury causing inflammation at the origin of the plantar fascia and is characterized by plantar heel pain that is provoked by taking the first few steps in the morning and by prolonged standing.
It is the most common clinical problem that causes inferomedial heel pain in adults.
It is estimated that more than two million people receive treatment for plantar fasciitis in the United States each year.
Despite its familiarity to physicians, the exact etiology of plantar fasciitis remains obscure.
The variety of treatments noted in the literature attests to the uncertainty of the etiology and pathogenesis of plantar fasciitis.
It has been suggested that the success of conservative care for the treatment of patients with plantar fasciitis requires a combination of treatment modalities.
Although many authors have stated that mechanical therapy should be considered a cornerstone of any effective treatment plan, some debate remains regarding the most effective form of mechanical treatment.
The literature provides evidence to support the use of dorsiflexion night splints and medial arch supports in the treatment of plantar fasciitis.
A night splint is used to address early morning pain by preventing contracture of the plantar fascia and Achilles tendon overnight.
An arch support, on the other hand, addresses the end of the day pain by preventing overstretch of the plantar fascia during prolonged weight bearing.
Therefore, both night splints and arch supports may be necessary to treat plantar fasciitis as they complement each other by both controlling nocturnal contracture of the plantar fascia and Achilles tendon and reducing stresses imposed on the plantar fascia during the day, respectively.
This prospective randomized study, to the best of our awareness, is the first that addresses this problem by examining the combined effect of these treatment modalities and comparing it to the effect of a night splint or arch support each by itself.
We hypothesize that the night splint and arch support together will be more effective in the treatment of plantar fasciitis than night splint or arch support alone in terms of increasing the range of pain-free passive ankle dorsiflexion, relieving heel tenderness and pain, and reducing disability imposed by the heel pain/plantar fasciitis.
A secondary hypothesis of this study is that those with limited passive dorsiflexion of the ankle will benefit from a night splint more than those with normal passive dorsiflexion of the ankle and those with a low medial longitudinal arch will benefit from an arch support more than those with a normal medial longitudinal arch in terms of the previously mentioned outcomes.
The range of motion will be measured with a goniometer; heel tenderness will be measured with a pressure algometer; and pain and disability will be measured by the Foot Function Index.
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15260
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- plantar heel pain
- pain is provoked by taking the first few steps in the morning, by standing after prolonged sitting, and/or by prolonged standing
- tenderness localized to the origin of the plantar fascia on the medial calcaneal tubercle
Exclusion Criteria:
- previous foot surgery
- foot trauma within the previous three months
- tarsal tunnel syndrome
- loss of plantar foot sensation
- foot pathology other than plantar fasciitis including tendonitis, bursitis, or calcaneus fracture
- generalized inflammatory disorders associated with the diagnosis of plantar fasciitis including rheumatoid arthritis, ankylosing spondylitis, Reiter's disease, gout, or lupus
- previous treatment of plantar fasciitis with dorsiflexion night splints and/or medial arch supports
- inability or unwillingness to discontinue current treatment modalities that are used for the purpose of plantar fasciitis
- participation in a worker's compensation program
- age of less than 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
the range of pain-free passive ankle joint dorsiflexion at baseline and 6 weeks
|
|
plantar heel tenderness at baseline and 6 weeks
|
|
plantar heel pain at baseline and 6 weeks
|
|
disability imposed by the heel pain/plantar fasciitis at baseline and 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
medial longitudinal arch height at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ahmad H Alghadir, MS, PT, University of Pittsburgh
- Study Chair: James Irrgang, PhD, PT, University of Pittsburgh
- Study Director: Anthony Delitto, PhD, PT, University of Pittsburgh
- Study Director: Dane Wukich, MD, University of Pittsburgh
- Study Director: Ray Burdett, PhD, PT, University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2005
Study Completion (Actual)
November 1, 2006
Study Registration Dates
First Submitted
September 20, 2005
First Submitted That Met QC Criteria
September 20, 2005
First Posted (Estimate)
September 22, 2005
Study Record Updates
Last Update Posted (Estimate)
May 20, 2008
Last Update Submitted That Met QC Criteria
May 19, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0506173
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.